Analysis of Multiple Myeloma Drug Efficacy
View ORCID ProfileAlexandre Matov
doi: https://doi.org/10.1101/2024.08.03.24311450
Alexandre Matov
1DataSet Analysis LLC, 155 Jackson St, San Francisco, CA 94111

Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted November 30, 2024.
Analysis of Multiple Myeloma Drug Efficacy
Alexandre Matov
medRxiv 2024.08.03.24311450; doi: https://doi.org/10.1101/2024.08.03.24311450
Subject Area
Subject Areas
- Addiction Medicine (412)
- Allergy and Immunology (726)
- Anesthesia (214)
- Cardiovascular Medicine (3112)
- Dermatology (263)
- Emergency Medicine (463)
- Epidemiology (13049)
- Forensic Medicine (13)
- Gastroenterology (862)
- Genetic and Genomic Medicine (4871)
- Geriatric Medicine (449)
- Health Economics (751)
- Health Informatics (3072)
- Health Policy (1109)
- Hematology (410)
- HIV/AIDS (963)
- Medical Education (453)
- Medical Ethics (120)
- Nephrology (502)
- Neurology (4641)
- Nursing (247)
- Nutrition (689)
- Oncology (2395)
- Ophthalmology (679)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (307)
- Palliative Medicine (88)
- Pathology (516)
- Pediatrics (1243)
- Primary Care Research (522)
- Public and Global Health (7206)
- Radiology and Imaging (1607)
- Respiratory Medicine (944)
- Rheumatology (461)
- Sports Medicine (403)
- Surgery (514)
- Toxicology (65)
- Transplantation (222)
- Urology (190)